Cargando…
Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma
BACKGROUND: Neuroblastoma (NB), a tumor of the primitive neural crest, despite aggressive treatment portends a poor long-term survival for patients with advanced high stage NB. New treatment strategies are required. METHODS: We investigated coordinated targeting of essential homeostatic regulatory f...
Autores principales: | Bayat Mokhtari, Reza, Baluch, Narges, Ka Hon Tsui, Micky, Kumar, Sushil, S. Homayouni, Tina, Aitken, Karen, Das, Bikul, Baruchel, Sylvain, Yeger, Herman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5326494/ https://www.ncbi.nlm.nih.gov/pubmed/28235409 http://dx.doi.org/10.1186/s12885-017-3126-7 |
Ejemplares similares
-
Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphane
por: Bayat Mokhtari, Reza, et al.
Publicado: (2019) -
Combination therapy in combating cancer
por: Mokhtari, Reza Bayat, et al.
Publicado: (2017) -
HIF-2α Suppresses p53 to Enhance the Stemness and Regenerative Potential of Human Embryonic Stem Cells
por: Das, Bikul, et al.
Publicado: (2012) -
Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis
por: Mokhtari, Reza Bayat, et al.
Publicado: (2021) -
Correction: Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis
por: Mokhtari, Reza Bayat, et al.
Publicado: (2022)